Sunnyou Medical announced on February 10 that in 2022, the company achieved operating revenue of 489 million yuan, a year-on-year decrease of 6.68%; net profit attributable to parent company was 121 million yuan, a year-on-year decrease of 39.98%. At the end of the reporting period, the company's total assets were 2.365 billion yuan, an increase of 8.36% from the beginning of 2022; owner's equity attributable to the parent company was 1.923 billion yuan, a decrease of 0.61% from the beginning of 2022. The change in performance was mainly due to the company's further increase in R&D and sales investment during the reporting period, resulting in increased R&D expenses and sales expenses, which led to a decline in profits and related financial indicators.
